Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-trace').style.display = (document.getElementById('cakeErr67f7206700167-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f7206700167-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-code').style.display = (document.getElementById('cakeErr67f7206700167-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-context').style.display = (document.getElementById('cakeErr67f7206700167-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f7206700167-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f7206700167-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21366, 'metaTitle' => 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'metaKeywords' => 'Ranbaxy,medicines,Supreme Court,Health', 'metaDesc' => ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21366 $metaTitle = 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji' $metaKeywords = 'Ranbaxy,medicines,Supreme Court,Health' $metaDesc = ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>SC ‘very serious’ tag on Ranbaxy charges-R Balaji</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material".</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">"What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said.</p><p align="justify">"What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India."</p><p align="justify">It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?"</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India."</p><p align="justify">The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008."</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy".</p><p align="justify">"Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said.</p><p align="justify">"There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'."</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-trace').style.display = (document.getElementById('cakeErr67f7206700167-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f7206700167-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-code').style.display = (document.getElementById('cakeErr67f7206700167-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-context').style.display = (document.getElementById('cakeErr67f7206700167-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f7206700167-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f7206700167-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21366, 'metaTitle' => 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'metaKeywords' => 'Ranbaxy,medicines,Supreme Court,Health', 'metaDesc' => ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21366 $metaTitle = 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji' $metaKeywords = 'Ranbaxy,medicines,Supreme Court,Health' $metaDesc = ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>SC ‘very serious’ tag on Ranbaxy charges-R Balaji</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material".</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">"What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said.</p><p align="justify">"What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India."</p><p align="justify">It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?"</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India."</p><p align="justify">The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008."</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy".</p><p align="justify">"Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said.</p><p align="justify">"There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'."</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-trace').style.display = (document.getElementById('cakeErr67f7206700167-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f7206700167-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-code').style.display = (document.getElementById('cakeErr67f7206700167-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f7206700167-context').style.display = (document.getElementById('cakeErr67f7206700167-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f7206700167-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67f7206700167-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21366, 'metaTitle' => 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'metaKeywords' => 'Ranbaxy,medicines,Supreme Court,Health', 'metaDesc' => ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;. </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> &quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said. </p> <p align="justify"> &quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot; </p> <p align="justify"> It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot; </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot; </p> <p align="justify"> The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot; </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;. </p> <p align="justify"> &quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said. </p> <p align="justify"> &quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot; </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21366 $metaTitle = 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji' $metaKeywords = 'Ranbaxy,medicines,Supreme Court,Health' $metaDesc = ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a &quot;very, very serious matter&quot; but refrained from issuing any orders till it received &quot;prima facie material&quot;.</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">&quot;What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated,&quot; the court said.</p><p align="justify">&quot;What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India.&quot;</p><p align="justify">It added: &quot;Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?&quot;</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had &quot;pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India.&quot;</p><p align="justify">The newspaper added: &quot;Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008.&quot;</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned &quot;all medicines supply by Ranbaxy&quot;.</p><p align="justify">&quot;Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports,&quot; the court said.</p><p align="justify">&quot;There is not a single hospital in this country which has said that &lsquo;We have found something wrong with the drug'.&quot;</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>SC ‘very serious’ tag on Ranbaxy charges-R Balaji</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material".</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">"What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said.</p><p align="justify">"What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India."</p><p align="justify">It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?"</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India."</p><p align="justify">The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008."</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy".</p><p align="justify">"Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said.</p><p align="justify">"There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'."</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material". </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> "What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said. </p> <p align="justify"> "What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India." </p> <p align="justify"> It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?" </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India." </p> <p align="justify"> The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008." </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy". </p> <p align="justify"> "Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said. </p> <p align="justify"> "There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'." </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21366, 'metaTitle' => 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'metaKeywords' => 'Ranbaxy,medicines,Supreme Court,Health', 'metaDesc' => ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material".</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">"What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said.</p><p align="justify">"What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India."</p><p align="justify">It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?"</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India."</p><p align="justify">The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008."</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy".</p><p align="justify">"Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said.</p><p align="justify">"There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'."</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21366, 'title' => 'SC ‘very serious’ tag on Ranbaxy charges-R Balaji', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material". </p> <p align="justify"> The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. </p> <p align="justify"> But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. </p> <p align="justify"> The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. </p> <p align="justify"> "What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said. </p> <p align="justify"> "What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India." </p> <p align="justify"> It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?" </p> <p align="justify"> The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. </p> <p align="justify"> A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India." </p> <p align="justify"> The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008." </p> <p align="justify"> Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy". </p> <p align="justify"> "Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said. </p> <p align="justify"> "There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'." </p> <p align="justify"> The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. </p> <p align="justify"> Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. </p>', 'credit_writer' => 'The Telegraph, 11 June, 2013, http://www.telegraphindia.com/1130611/jsp/nation/story_16994668.jsp#.Uba889jcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'sc-very-serious-tag-on-ranbaxy-charges-r-balaji-21512', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21512, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21366 $metaTitle = 'LATEST NEWS UPDATES | SC ‘very serious’ tag on Ranbaxy charges-R Balaji' $metaKeywords = 'Ranbaxy,medicines,Supreme Court,Health' $metaDesc = ' -The Telegraph New Delhi: The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>The Supreme Court today observed that even if there was a grain of truth in the charges that Ranbaxy was supplying adulterated drugs, it was a "very, very serious matter" but refrained from issuing any orders till it received "prima facie material".</p><p align="justify">The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country.</p><p align="justify">But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant.</p><p align="justify">The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday.</p><p align="justify">"What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said.</p><p align="justify">"What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India."</p><p align="justify">It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?"</p><p align="justify">The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world.</p><p align="justify">A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India."</p><p align="justify">The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008."</p><p align="justify">Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy".</p><p align="justify">"Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said.</p><p align="justify">"There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'."</p><p align="justify">The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India.</p><p align="justify">Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
SC ‘very serious’ tag on Ranbaxy charges-R Balaji |
-The Telegraph
The court said that drug-testing standards in the US were different from those in India, and what was happening in America might not necessarily be happening in this country. But it added that if sufficient material were brought before it, the court would be willing to direct the government to act against the pharma giant. The bench of Justices Gyan Sudha Misra and Madan B. Lokur made the oral observation while asking petitioner Manohar Lal Sharma, a lawyer, to further research the matter. It posted the public interest litigation for hearing on Wednesday. "What is the material placed by you before us to say the medicines are adulterated? We must be fully satisfied that the drugs marketed are adulterated," the court said. "What is the material placed by you to say that the drugs are... part of the same transactions coming to India? Those supplied in the US may not be the same (as those) in India." It added: "Even if there is a grain of truth (in the allegations), it is a very, very serious matter which cannot be overlooked. By all means, we would be anxious to interfere.... But where is the prima facie material in the writ petition?" The court said the petitioner had not placed the order, if any, passed by America's Food and Drug Administration fining Ranbaxy the equivalent of Rs 2,900 crore on charges of supplying adulterated and substandard drugs in various parts of the world. A New York Times report said on May 13 that Ranbaxy had "pleaded guilty... to federal drug safety violations and will pay $500 million in fines to resolve claims that it sold sub-par drugs and made false statements to the Food and Drug Administration about its manufacturing practices at two factories in India." The newspaper added: "Ranbaxy has been operating under a consent decree with the Food and Drug Administration since last year after federal officials identified a host of manufacturing lapses at plants in India and one in the United States, and concluded that the company... submitted false data to the FDA. Ranbaxy has not exported drugs from the two Indian factories, known as Paonta Sahib and Dewas, to the United States since 2008." Sharma's petition says Jaslok Hospital of Mumbai has banned "all medicines supply by Ranbaxy". "Of course, we have come across reports that some (Indian) hospitals have banned it but... we cannot pass any order on the basis of newspaper reports," the court said. "There is not a single hospital in this country which has said that ‘We have found something wrong with the drug'." The petitioner's counsel agreed to place the material sought before the court. The bench asked Sharma to make the Union commerce ministry a party to the case along with the Directorate of Drug Control Administration and other authorities regulating the manufacture, sale and supply of medicines in India. Sharma's petition has sought registration of criminal cases under the penal code and the Drugs and Cosmetics Act, 1947, against the pharma company's officials for allegedly cheating patients by supplying substandard and adulterated drugs. The charges carry a maximum punishment of life imprisonment. |